Clinically Significant Bacteremia
2
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Related Conditions
Often studied with 8 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 2 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.
Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study
Research Network
Active Sponsors
- JESUS RODRIGUEZ BAÑO1
- Spanish Network for Research in Infectious Diseases1
- European Society of Clinical Microbiology and Infectious Diseases1
Top Investigators
Hospital Universitario Virgen Macarena, IBIS, Seville, Spain.
Hospital Universitario Virgen Macarena, IBIS, Seville, Spain.
Hospital Universitario Virgen Macarena, IBIS, Seville, Spain.
Spanish Network for Research in Infectious Diseases
Hospital Universitario Reina Sofía/IMIBIC/UCO, Córdoba, Spain.
Related Conditions
- Organ Transplantation1
- Bacterial Infections1
- Infection1
- Bacteremia1
- Inflammation1